Wednesday, November 4, 2026||
MultiKhabarMultiKhabar

Rituximab Linked to 10-fold Higher IBD Risk in MS

ME
Medscape
By Medscape
Share:WhatsAppFacebookX (Twitter)Telegram
EXECUTIVE SUMMARY

Rituximab Linked to 10-fold Higher IBD Risk in MS Medscape

Key Takeaways

  • Rituximab Linked to 10-fold Higher IBD Risk in MS.
  • Rituximab Linked to 10-fold Higher IBD Risk in MS Medscape Rituximab Linked to 10-fold Higher IBD Risk in MS  Medscape

Rituximab Linked to 10-fold Higher IBD Risk in MS  Medscape

Share:WhatsAppFacebookX (Twitter)Telegram

Read Complete Original Article

Published originally on Medscape

Visit Publisher Site →

Related News

🇸🇪 Sweden
Multikhabar App

All Information In One Place

Real-time headlines from trusted sources. Get the app now — stay updated, inspired, and ahead with breaking news!

Get it on Google Play